Motley Fool Australia

Motley Fool Australia

Since 1993, millions of investors have trusted The Motley Fool for simple, down-to-earth investing research.

Sigma: A return to profit, but not in the clear

Sigma Pharmaceutical Limited (ASX: SIP) today announced a return to full-year profit, after a tough few years. It booked a $49 million profit, after a loss of $235 million last year. Excluding discontinued operations, the company improved to a $50 million profit, up from a $73 million loss in the prior year.

We outlined some of the pharmacy wholesaler’s recent problems last week, including overpaying for acquisitions, suffering the loss of Pfizer’s drug distribution business (Pfizer is distributing its products direct to pharmacies, bypassing Sigma and the other wholesalers, including Australian Pharmaceutical Industries Ltd (ASX: API)) and most recently a strike at its Rowville distribution centre.

The company will pay a full-year dividend of 2 cents, and a special dividend of 1.5 cents, both fully-franked, capping a phoenix-like year for the company, with the shares rebounding from a low of $0.28 12 months ago to $0.645 in afternoon trade today.

That jump looks impressive – and it is, if you were lucky enough to buy shares at their lows. The shares are still down from a high of $0.89 they hit 2.5 years ago and an all-time high of $2.16 in 2005, so long term shareholders will appreciate the up-tick, but there’s a long way to go before they are made whole.

Risks still abound – with the company highlighting the upcoming cuts to the Pharmaceutical Benefits Scheme and the chance that another major pharmaceutical supplier may follow Pfizer’s lead and deliver its products directly.

The management team deserve plaudits for righting the ship, but there’s still a long way to go before it’s at cruising speed and under full sail – and a safe distance from the menacing rocks that are still well in sight.

If you are looking for ASX investing ideas, look no further than “The Motley Fool’s Top Stock for 2012.” In this free report, Investment Analyst Dean Morel names his top pick for 2012…and beyond. Click here now to find out the name of this small but growing telecommunications company. But hurry – the report is free for only a limited period of time.

More reading

Scott Phillips is a Motley Fool investment analyst. You can follow him on Twitter @TMFGilla. The Motley Fool’s purpose is to educate, amuse and enrich investors. This article contains general investment advice only (under AFSL 400691)

The One ASX Pick You MUST Add to Your Portfolio

Top Motley Fool analysts just identified their #1 ASX pick for 2014, a small-cap stock that could be poised for big gains (and offers a fat, fully franked dividend!).

Discover all the details now, including the name and code, in this FREE investment report, "The Motley Fool’s Top Stock for 2014."

By clicking this button, you agree that we may contact you to keep you informed about services we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy. The Motley Fool Australia Pty Ltd (ACN 146 988 052) holds an Australia Financial Service License: 400691. Please refer to our Financial Services Guide (FSG) for more information.

See all posts by Scott Phillips
The Motley Fool